Quick Answer
AYTU BIOPHARMA, INC reported Stockholders Equity of $18.97 million for the year ending 2025.
- AYTU BIOPHARMA, INC showed a decrease of -31.6% in Stockholders Equity from 2024 to 2025.
- This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
- XBRL data for this metric is available from 2006 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: -$45.0 thousand | Q4 2014: -$44.1 thousand | Q1 2015: -$52.9 thousand | Q1 2015: $551.3 thousand | Q3 2015: $13.41 million | Q4 2015: $15.26 million | Q1 2016: $17.57 million | Q3 2016: $7.19 million | Q4 2016: $10.45 million | Q1 2017: $8.52 million | Q3 2017: $6.35 million | Q4 2017: $3.03 million | Q1 2018: $12.75 million | Q3 2018: $10.13 million | Q4 2018: $19.90 million | Q1 2019: $16.04 million | Q2 2019: $7.09 million | Q3 2019: $2.32 million | Q4 2019: $17.09 million | Q1 2020: $85.70 million | Q2 2020: $95.02 million | Q3 2020: $91.06 million | Q4 2020: $112.69 million | Q1 2021: $143.15 million | Q3 2021: $111.50 million | Q4 2021: $105.54 million | Q1 2022: $61.14 million | Q3 2022: $48.35 million | Q4 2022: $45.82 million | Q1 2023: $40.91 million | Q3 2023: $32.17 million | Q4 2023: $32.85 million | Q1 2024: $30.78 million | Q2 2024: $27.72 million | Q3 2024: $29.83 million | Q4 2024: $30.77 million | Q1 2025: $34.90 million | Q2 2025: $18.97 million | Q3 2025: $23.17 million | Q4 2025: $14.20 million.
- Over the full 21 years of available data (2006 to 2025), AYTU BIOPHARMA, INC's Stockholders Equity has grown by 32,629.9%.
- Historical annual values: Fiscal year 2025: $18.97 million | Fiscal year 2024: $27.72 million | Fiscal year 2023: $39.36 million | Fiscal year 2022: $44.31 million | Fiscal year 2021: $137.57 million | Fiscal year 2020: $95.02 million | Fiscal year 2019: $7.09 million | Fiscal year 2018: $13.42 million | Fiscal year 2017: $4.00 million | Fiscal year 2016: $10.09 million | Fiscal year 2015: $15.62 million | Fiscal year 2014: $5.37 million | Fiscal year 2013: -$110.9 thousand | Fiscal year 2013: $9.81 million | Fiscal year 2012: -$69.7 thousand | Fiscal year 2011: -$35.6 thousand | Fiscal year 2010: -$55.6 thousand | Fiscal year 2009: -$13.6 thousand | Fiscal year 2008: $26.0 thousand | Fiscal year 2007: $18.8 thousand | Fiscal year 2006: $57.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: